ePrints

A phase I and pharmacodynamic study of a 7 day infusion schedule of the DNMT1 antisense compound MG98.

Lookup NU author(s): Mark Leslie, Julieann Sludden, Professor Ruth Plummer, Professor Alastair GreystokeORCiD, Professor Alan Calvert, Professor Alan Boddy

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Vidal L, Leslie M, Sludden J, Griffin MG, Plummer R, Judson I, Lee C, Greystoke A, Calvert AH, Boddy AV

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 42nd Meeting of the American Society of Clinical Oncology Annual Meeting Proceedings

Year of Conference: 2005

Pages: 209 no 3070

Publisher: Journal of Clinical Oncology, American Society of Clinical Oncology

URL: http://meeting.ascopubs.org/cgi/content/abstract/23/16_suppl/3070

Library holdings: Search Newcastle University Library for this item

ISBN:

Share